One emerging cancer-associated target is Receptor tyrosine kinase like Orphan Receptor 1 (ROR1), which is an oncofetal RTK-like protein that is highly expressed in embryogenesis and minimally expressed in developed tissue [32,33]. Here, ROR1 is linked to cancer.